Fennec Pharmaceuticals
FENC on XNAS, Fennec Pharmaceuticals Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
454K
-6.8% vs the report before
Short interest, % of shares outstanding
1.3%
35.3M shares outstanding (10 Nov 2026)
Days to cover
3.9
short interest / daily volume
Short sale volume share (20 Nov 2026)
28%
1-year median 37%
Sharp changes
8
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 454K shares sold short, 3.9 days to cover |
| 15 Oct 2026: 488K shares sold short, 3.8 days to cover |
| 30 Sep 2026: 513K shares sold short, 3.9 days to cover |
| 15 Sep 2026: 545K shares sold short, 2.1 days to cover |
| 31 Aug 2026: 521K shares sold short, 2.0 days to cover |
| 14 Aug 2026: 532K shares sold short, 2.2 days to cover |
| 31 Jul 2026: 616K shares sold short, 5.3 days to cover |
| 15 Jul 2026: 609K shares sold short, 3.3 days to cover |
| 30 Jun 2026: 489K shares sold short, 1.3 days to cover |
| 15 Jun 2026: 451K shares sold short, 2.0 days to cover |
| 29 May 2026: 498K shares sold short, 1.4 days to cover |
| 15 May 2026: 623K shares sold short, 1.6 days to cover |
| 30 Apr 2026: 1.1M shares sold short, 9.0 days to cover |
| 15 Apr 2026: 931K shares sold short, 5.2 days to cover |
| 31 Mar 2026: 913K shares sold short, 3.0 days to cover |
| 13 Mar 2026: 807K shares sold short, 6.4 days to cover |
| 27 Feb 2026: 824K shares sold short, 7.1 days to cover |
| 13 Feb 2026: 812K shares sold short, 7.7 days to cover |
| 30 Jan 2026: 770K shares sold short, 8.2 days to cover |
| 15 Jan 2026: 742K shares sold short, 5.5 days to cover |
| 31 Dec 2025: 778K shares sold short, 3.7 days to cover |
| 15 Dec 2025: 859K shares sold short, 5.7 days to cover |
| 28 Nov 2025: 882K shares sold short, 4.0 days to cover |
| 14 Nov 2025: 1.1M shares sold short, 7.3 days to cover |
| 31 Oct 2025: 981K shares sold short, 13.6 days to cover |
| 15 Oct 2025: 1.3M shares sold short, 17.7 days to cover |
| 30 Sep 2025: 1.3M shares sold short, 11.6 days to cover |
| 15 Sep 2025: 1.3M shares sold short, 27.7 days to cover |
| 29 Aug 2025: 1.2M shares sold short, 19.7 days to cover |
| 15 Aug 2025: 1.3M shares sold short, 18.8 days to cover |
| 31 Jul 2025: 1.3M shares sold short, 28.2 days to cover |
| 15 Jul 2025: 1.3M shares sold short, 18.8 days to cover |
| 30 Jun 2025: 1.3M shares sold short, 15.6 days to cover |
| 13 Jun 2025: 1.4M shares sold short, 16.4 days to cover |
| 30 May 2025: 1.4M shares sold short, 9.8 days to cover |
| 15 May 2025: 1.5M shares sold short, 24.1 days to cover |
| 30 Apr 2025: 1.5M shares sold short, 33.6 days to cover |
| 15 Apr 2025: 1.4M shares sold short, 14.4 days to cover |
| 31 Mar 2025: 1.5M shares sold short, 15.2 days to cover |
| 14 Mar 2025: 1.4M shares sold short, 10.5 days to cover |
| 28 Feb 2025: 1.9M shares sold short, 48.3 days to cover |
| 14 Feb 2025: 2.0M shares sold short, 39.7 days to cover |
| 31 Jan 2025: 2.0M shares sold short, 32.9 days to cover |
| 15 Jan 2025: 2.0M shares sold short, 31.1 days to cover |
| 31 Dec 2024: 2.0M shares sold short, 22.6 days to cover |
| 13 Dec 2024: 2.1M shares sold short, 14.4 days to cover |
| 29 Nov 2024: 2.1M shares sold short, 10.2 days to cover |
| 15 Nov 2024: 1.9M shares sold short, 14.0 days to cover |
| 31 Oct 2024: 1.8M shares sold short, 21.2 days to cover |
| 15 Oct 2024: 1.8M shares sold short, 29.0 days to cover |
| 30 Sep 2024: 1.8M shares sold short, 18.1 days to cover |
| 13 Sep 2024: 1.8M shares sold short, 24.6 days to cover |
| 30 Aug 2024: 1.8M shares sold short, 20.9 days to cover |
| 15 Aug 2024: 1.9M shares sold short, 18.7 days to cover |
| 31 Jul 2024: 1.9M shares sold short, 29.6 days to cover |
| 15 Jul 2024: 2.0M shares sold short, 27.9 days to cover |
| 28 Jun 2024: 1.8M shares sold short, 10.4 days to cover |
| 14 Jun 2024: 1.8M shares sold short, 17.8 days to cover |
| 31 May 2024: 1.8M shares sold short, 9.9 days to cover |
| 15 May 2024: 1.7M shares sold short, 7.5 days to cover |
What the numbers say
- 454K shares sold short on 30 Oct 2026, 1.3% of shares outstanding, 3.9 days to cover; -6.8% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
8 in all loaded history, strongest first
Fennec Pharmaceuticals had 1.4M shares sold short in the 15 Sep 2020 report, 8.7× the same report last year.
Same report last year: 160K; its normal report is 541K.
See the evidence
- This period
- 1.4M (the 15 Sep 2020 report)
- Normal report (median of 24 earlier)
- 541K
- Typical spread (median absolute deviation)
- 131K
- How far from its usual level
- +4.3
- Same report last year
- 160K
- History used
- 991 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Fennec Pharmaceuticals had 1.4M shares sold short in the 30 Sep 2020 report, 9.1× the same report last year.
Same report last year: 154K; its normal report is 554K.
See the evidence
- This period
- 1.4M (the 30 Sep 2020 report)
- Normal report (median of 24 earlier)
- 554K
- Typical spread (median absolute deviation)
- 133K
- How far from its usual level
- +4.3
- Same report last year
- 154K
- History used
- 1,006 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Fennec Pharmaceuticals had 900K shares sold short in the 31 Jan 2023 report, 3.1× the same report last year.
Same report last year: 291K; its normal report is 295K.
See the evidence
- This period
- 900K (the 31 Jan 2023 report)
- Normal report (median of 24 earlier)
- 295K
- Typical spread (median absolute deviation)
- 98K
- How far from its usual level
- +4.2
- Same report last year
- 291K
- History used
- 1,859 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Fennec Pharmaceuticals had 657K shares sold short in the 30 Dec 2022 report, 1.8× the same report last year.
Same report last year: 360K; its normal report is 295K.
See the evidence
- This period
- 657K (the 30 Dec 2022 report)
- Normal report (median of 24 earlier)
- 295K
- Typical spread (median absolute deviation)
- 61K
- How far from its usual level
- +4.0
- Same report last year
- 360K
- History used
- 1,827 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Fennec Pharmaceuticals had 701K shares sold short in the 13 Jan 2023 report, 2.2× the same report last year.
Same report last year: 315K; its normal report is 295K.
See the evidence
- This period
- 701K (the 13 Jan 2023 report)
- Normal report (median of 24 earlier)
- 295K
- Typical spread (median absolute deviation)
- 70K
- How far from its usual level
- +3.9
- Same report last year
- 315K
- History used
- 1,841 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Fennec Pharmaceuticals had 1.0M shares sold short in the 15 Feb 2023 report, 3.4× the same report last year.
Same report last year: 299K; its normal report is 301K.
See the evidence
- This period
- 1.0M (the 15 Feb 2023 report)
- Normal report (median of 24 earlier)
- 301K
- Typical spread (median absolute deviation)
- 130K
- How far from its usual level
- +3.7
- Same report last year
- 299K
- History used
- 1,874 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.